YOLFTbeta
Seegene Inc

Seegene Inc

096530 · KQ · Healthcare / Biotechnology

24,650.00KRW-450.00 (-1.79%)

Price History

Full chart

Market Stats

Previous Close25,100.00
Open25,100.00
Day Range24,500.00 – 25,600.00
52-Week Range21,360.46 – 37,650.00
Volume267.88K
Market Cap1.68T
P/E (TTM)0.00
Forward P/E70.42
Dividend Yield3.22%
Beta0.92
50-Day Avg31,309.00
200-Day Avg27,391.50

About

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis detection products. The company also provides other products for the detection of SNPs in factor II, factor V, and MTHFR genes. The company has a collaboration with Werfen for the joint development of syndromic qPCR assays. Seegene, Inc. was founded in 2000 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEODr. Jong-Yoon Chun
  • Employees761
  • HeadquartersTaewon Building, Seoul, South Korea, 05548, Korea
  • Websitehttps://www.seegene.com

Leadership

  • Dr. Jong-Yoon ChunFounder, CEO, CTO & Chairman · b. 1957
  • Mr. Dae-Hoon LeeExecutive Director & Head of Diagnostics Business Division
  • Mr. Jin-Soo ChoiExecutive VP & Director · b. 1952
  • Dr. Richard S. Creager Ph.D.CEO of Seegene Technologies · b. 1953

Financials

Income Statement

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue51.71B58.99B64.41B65.14B73.69B86.85B102.26B121.95B1.13T1.37T853.56B367.38B414.25B474.23B
Growth (%)-+14.08%+9.18%+1.13%+13.14%+17.86%+17.74%+19.25%+822.66%+21.83%-37.73%-56.96%+12.76%+14.48%
Cost of Revenue16.61B15.21B16.40B18.39B21.26B28.67B34.61B40.66B267.52B366.01B357.49B155.47B175.63B170.37B
Gross Profit35.10B43.78B46.83B46.75B52.44B58.19B67.65B81.29B857.69B1.00T496.07B211.91B238.62B303.86B
Gross Margin67.88%74.21%72.70%71.77%71.16%66.99%66.15%66.66%76.22%73.30%58.12%57.68%57.60%64.08%
Operating Expense22.88B29.69B35.71B38.87B42.72B53.16B57.32B58.07B182.17B338.42B299.77B241.46B283.06B269.31B
Operating Income12.23B14.09B11.12B7.88B9.72B5.03B10.33B23.22B675.53B666.40B196.31B-29.55B-44.44B34.55B
Operating Margin23.64%23.88%17.26%12.10%13.19%5.79%10.11%19.04%60.04%48.61%23.00%-8.04%-10.73%7.29%
EBITDA----------288.53B70.02B67.54B130.91B
EBITDA Margin----------33.80%19.06%16.31%27.61%
Net Income9.10B9.57B9.14B6.77B7.12B1.99B10.73B26.67B502.28B536.56B182.14B669.01M-20.34B48.27B
Net Income Margin17.60%16.23%14.19%10.40%9.67%2.29%10.49%21.87%44.64%39.14%21.34%0.18%-4.91%10.18%
R&D--7.64B2.63B3.43B12.60B10.28B9.65B25.95B75.54B94.74B72.73B69.37B66.26B
R&D as % of Total Revenue--11.86%4.04%4.66%14.51%10.05%7.91%2.31%5.51%11.10%19.80%16.75%13.97%
Interest Expense000000001.36B3.76B5.03B5.72B5.80B4.47B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.12%0.27%0.59%1.56%1.40%0.94%

Balance Sheet

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets83.62B129.04B138.45B194.05B207.62B164.84B163.81B195.72B1.09T1.49T1.39T1.25T1.21T1.24T
Total Liabilities41.68B44.59B43.62B58.96B65.65B39.80B35.78B43.17B449.26B408.31B243.01B221.05B223.80B219.98B
Total Equity--94.75B135.09B141.97B125.04B128.03B152.55B645.32B1.08T1.15T1.03T978.63B1.02T
Cash4.31B25.96B19.53B40.87B49.67B27.75B32.59B49.08B308.12B432.13B521.35B190.34B259.70B225.57B
Total Debt----49.20B19.11B9.57B11.88B95.75B-----

Cash Flow

Currency: KRW2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow3.67B-2.89B6.78B-3.07B16.56B10.12B14.01B27.14B383.16B334.02B319.01B94.93B85.39B149.33B
Investing Cash Flow-9.70B-9.20B-10.74B-25.48B-9.82B6.05B959.96M-6.91B-192.67B-102.67B-103.98B-278.33B34.67B-
Financing Cash Flow-7.93B33.72B-3.90B49.72B1.86B-37.51B-10.14B-4.18B71.91B-110.30B-144.50B-156.70B-63.70B-
Capital Expenditure2.59B1.24B2.64B7.67B10.72B4.83B2.93B4.07B174.03B61.66B63.26B31.88B43.63B40.47B
Free Cash Flow--------207.89B267.91B246.56B63.05B41.76B108.87B
Dividends Paid-----2.60B2.60B2.60B2.60B70.02B51.11B38.08B36.92B36.90B
FCF to OCF--------54.26%80.21%77.29%66.42%48.91%72.90%
Dividend Paid to FCF--------1.25%26.14%20.73%60.39%88.41%33.89%

Earnings

Report DateSep 30, 2010Dec 31, 2010May 13, 2011Aug 12, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013Apr 1, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Nov 19, 2014Mar 3, 2015May 8, 2015Aug 28, 2015Nov 10, 2015Feb 21, 2016May 13, 2016Aug 16, 2016Nov 14, 2016Mar 16, 2017May 10, 2017Aug 14, 2017Nov 14, 2017Feb 22, 2018May 15, 2018Aug 14, 2018Nov 14, 2018Feb 22, 2019May 14, 2019Aug 14, 2019Nov 14, 2019Feb 26, 2020May 13, 2020Aug 13, 2020Nov 11, 2020Mar 11, 2021May 12, 2021Aug 13, 2021Nov 11, 2021Feb 17, 2022May 13, 2022Aug 12, 2022Nov 11, 2022Feb 17, 2023May 12, 2023Aug 11, 2023Nov 10, 2023Mar 22, 2024May 10, 2024Aug 9, 2024Nov 8, 2024Feb 26, 2025May 8, 2025Aug 8, 2025Nov 7, 2025Feb 25, 2026May 8, 2026Aug 7, 2026Nov 6, 2026
EPS Estimate--33.0183.47------92.00--------59.50--43.5741.4349.57120.6462.7675.3082.7613.00135.61125.59132.6723.6751.92-52.6973.01-2506.272274.762472.96---1869.122881.521485.061146.66----------------
EPS Actual19.6230.6733.6034.1390.5330.9345.7961.4234.4844.2755.3363.5550.9927.6748.5634.9048.6149.7433.8935.6658.131.4123.5039.00-10.0084.00-14.0027.5053.504.0094.0079.0035.00209.0098.50180.00113.50108.50646.502513.502915.003587.003166.892225.121792.823171.003195.00494.00-217.0052.0041.98-53.89-100.58126.69-45.07521.0736.11-952.79626.33-2.65315.75107.08754.01569.28-
Surprise--1.79%-59.11%-------39.86%---------40.07%---46.06%-5.87%-120.17%-30.37%-122.31%-63.48%-35.36%-69.23%-30.68%-37.10%-73.62%782.97%89.71%-115.41%48.61%-0.29%28.15%45.05%---69.65%10.88%-66.74%-118.92%----------------
Timing--After-hoursAfter-hours------After-hours-----Pre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap1.68T
Enterprise Value1.10T
Trailing P/E0.00
Forward P/E70.42
Price / Sales3.30
Price / Book1.49
Revenue (TTM)509.27B
Gross Profit (TTM)337.37B
EBITDA129.03B
Profit Margin18.01%
Operating Margin15.87%
Return on Equity9.04%
Return on Assets3.11%
Shares Outstanding45.56M
Shares Float30.54M
Beta0.92
Dividend Yield3.22%
Dividend Rate1,200.00
Payout Ratio40.09%

Dividends

20262×
300.00Jun 29, 2026200.00Mar 30, 2026
20254×
200.00Dec 29, 2025200.00Sep 29, 2025200.00Jun 27, 2025200.00Mar 28, 2025
20244×
200.00Dec 27, 2024200.00Sep 27, 2024200.00Jun 27, 2024200.00Mar 28, 2024
20234×
200.00Dec 27, 2023200.00Sep 26, 2023200.00Jun 29, 2023200.00Mar 30, 2023
20224×
200.00Dec 28, 2022200.00Sep 29, 2022200.00Jun 29, 2022200.00Mar 30, 2022
20213×
400.00Dec 29, 2021200.00Sep 29, 2021400.00Jun 29, 2021
20201×
750.00Dec 29, 2020
20191×
50.00Dec 27, 2019

Stock Splits

  • Apr 23, 20212:1
  • Dec 16, 20143:2
  • Jan 16, 20135:4
  • Nov 30, 20102:1